List of Tables
Table 1. Next Generation Cancer Treatment Market Trends
Table 2. Next Generation Cancer Treatment Market Drivers & Opportunity
Table 3. Next Generation Cancer Treatment Market Challenges
Table 4. Next Generation Cancer Treatment Market Restraints
Table 5. Global Next Generation Cancer Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Next Generation Cancer Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Next Generation Cancer Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Next Generation Cancer Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Next Generation Cancer Treatment
Table 10. Global Next Generation Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Next Generation Cancer Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Next Generation Cancer Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Next Generation Cancer Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Next Generation Cancer Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Next Generation Cancer Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Next Generation Cancer Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Next Generation Cancer Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Next Generation Cancer Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Next Generation Cancer Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Next Generation Cancer Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Next Generation Cancer Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Next Generation Cancer Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Next Generation Cancer Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Next Generation Cancer Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Next Generation Cancer Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Next Generation Cancer Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Next Generation Cancer Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Next Generation Cancer Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. OncoGenex Pharmaceuticals, Inc. Basic Information List
Table 32. OncoGenex Pharmaceuticals, Inc. Description and Business Overview
Table 33. OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Next Generation Cancer Treatment Business of OncoGenex Pharmaceuticals, Inc. (2019-2024)
Table 35. OncoGenex Pharmaceuticals, Inc. Recent Developments
Table 36. Cytokinetics Inc. Basic Information List
Table 37. Cytokinetics Inc. Description and Business Overview
Table 38. Cytokinetics Inc. Next Generation Cancer Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Next Generation Cancer Treatment Business of Cytokinetics Inc. (2019-2024)
Table 40. Cytokinetics Inc. Recent Developments
Table 41. Hospira Inc. Basic Information List
Table 42. Hospira Inc. Description and Business Overview
Table 43. Hospira Inc. Next Generation Cancer Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Next Generation Cancer Treatment Business of Hospira Inc. (2019-2024)
Table 45. Hospira Inc. Recent Developments
Table 46. GlaxoSmithKline plc Basic Information List
Table 47. GlaxoSmithKline plc Description and Business Overview
Table 48. GlaxoSmithKline plc Next Generation Cancer Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Next Generation Cancer Treatment Business of GlaxoSmithKline plc (2019-2024)
Table 50. GlaxoSmithKline plc Recent Developments
Table 51. Boehringer Ingelheim GmbH Basic Information List
Table 52. Boehringer Ingelheim GmbH Description and Business Overview
Table 53. Boehringer Ingelheim GmbH Next Generation Cancer Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Next Generation Cancer Treatment Business of Boehringer Ingelheim GmbH (2019-2024)
Table 55. Boehringer Ingelheim GmbH Recent Developments
Table 56. Bayer HealthCare AG Basic Information List
Table 57. Bayer HealthCare AG Description and Business Overview
Table 58. Bayer HealthCare AG Next Generation Cancer Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Next Generation Cancer Treatment Business of Bayer HealthCare AG (2019-2024)
Table 60. Bayer HealthCare AG Recent Developments
Table 61. Abbott Laboratories Basic Information List
Table 62. Abbott Laboratories Description and Business Overview
Table 63. Abbott Laboratories Next Generation Cancer Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Next Generation Cancer Treatment Business of Abbott Laboratories (2019-2024)
Table 65. Abbott Laboratories Recent Developments
Table 66. Walking Fish Therapeutics Basic Information List
Table 67. Walking Fish Therapeutics Description and Business Overview
Table 68. Walking Fish Therapeutics Next Generation Cancer Treatment Products, Services and Solutions
Table 69. Revenue (US$ Million) in Next Generation Cancer Treatment Business of Walking Fish Therapeutics (2019-2024)
Table 70. Walking Fish Therapeutics Recent Developments
Table 71. Kojin Therapeutics Basic Information List
Table 72. Kojin Therapeutics Description and Business Overview
Table 73. Kojin Therapeutics Next Generation Cancer Treatment Products, Services and Solutions
Table 74. Revenue (US$ Million) in Next Generation Cancer Treatment Business of Kojin Therapeutics (2019-2024)
Table 75. Kojin Therapeutics Recent Developments
Table 76. Scorpion Therapeutics Basic Information List
Table 77. Scorpion Therapeutics Description and Business Overview
Table 78. Scorpion Therapeutics Next Generation Cancer Treatment Products, Services and Solutions
Table 79. Revenue (US$ Million) in Next Generation Cancer Treatment Business of Scorpion Therapeutics (2019-2024)
Table 80. Scorpion Therapeutics Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Next Generation Cancer Treatment Downstream Customers
Table 84. Next Generation Cancer Treatment Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Next Generation Cancer Treatment Product Picture
Figure 2. Global Next Generation Cancer Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Next Generation Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Next Generation Cancer Treatment Report Years Considered
Figure 5. Global Next Generation Cancer Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Next Generation Cancer Treatment Revenue in 2023
Figure 7. Next Generation Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. CAR-T Therapy Picture
Figure 9. Targeted Cancer Therapy Picture
Figure 10. Others Picture
Figure 11. Global Next Generation Cancer Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Next Generation Cancer Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Lung Cancer
Figure 14. Product Picture of Colorectal Cancer
Figure 15. Product Picture of Stomach Cancer
Figure 16. Product Picture of Breast Cancer
Figure 17. Product Picture of Liver Cancer
Figure 18. Product Picture of Others
Figure 19. Global Next Generation Cancer Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Next Generation Cancer Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Next Generation Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Next Generation Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Next Generation Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Next Generation Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Next Generation Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Next Generation Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Next Generation Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Next Generation Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Next Generation Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Next Generation Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Next Generation Cancer Treatment Sales Value (%), (2019-2030)
Figure 32. United States Next Generation Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Next Generation Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Next Generation Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Next Generation Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Next Generation Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Next Generation Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 38. China Next Generation Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Next Generation Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. China Next Generation Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Next Generation Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Next Generation Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Next Generation Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Next Generation Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Next Generation Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Next Generation Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Next Generation Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Next Generation Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Next Generation Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. India Next Generation Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Next Generation Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 52. India Next Generation Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 53. Next Generation Cancer Treatment Industrial Chain
Figure 54. Next Generation Cancer Treatment Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
